These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29858790)

  • 61. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.
    Johnson M; Karanikolas BD; Priceman SJ; Powell R; Black ME; Wu HM; Czernin J; Huang SC; Wu L
    J Nucl Med; 2009 May; 50(5):757-64. PubMed ID: 19372484
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents.
    Bhatnagar P; Alauddin M; Bankson JA; Kirui D; Seifi P; Huls H; Lee DA; Babakhani A; Ferrari M; Li KC; Cooper LJ
    Sci Rep; 2014 Mar; 4():4502. PubMed ID: 24675806
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of a universal anti-polyethylene glycol reporter gene for noninvasive imaging of PEGylated probes.
    Chuang KH; Wang HE; Cheng TC; Tzou SC; Tseng WL; Hung WC; Tai MH; Chang TK; Roffler SR; Cheng TL
    J Nucl Med; 2010 Jun; 51(6):933-41. PubMed ID: 20484433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.
    Ashmore-Harris C; Iafrate M; Saleem A; Fruhwirth GO
    Mol Ther; 2020 Jun; 28(6):1392-1416. PubMed ID: 32243834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.
    Milone MC; Fish JD; Carpenito C; Carroll RG; Binder GK; Teachey D; Samanta M; Lakhal M; Gloss B; Danet-Desnoyers G; Campana D; Riley JL; Grupp SA; June CH
    Mol Ther; 2009 Aug; 17(8):1453-64. PubMed ID: 19384291
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging.
    Hung SC; Deng WP; Yang WK; Liu RS; Lee CC; Su TC; Lin RJ; Yang DM; Chang CW; Chen WH; Wei HJ; Gelovani JG
    Clin Cancer Res; 2005 Nov; 11(21):7749-56. PubMed ID: 16278396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
    Lee SH; Soh H; Chung JH; Cho EH; Lee SJ; Ju JM; Sheen JH; Kim H; Oh SJ; Lee SJ; Chung J; Choi K; Kim SY; Ryu JS
    PLoS One; 2020; 15(1):e0223814. PubMed ID: 31910217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
    McKnight BN; Viola-Villegas NT
    Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.
    Tavaré R; McCracken MN; Zettlitz KA; Knowles SM; Salazar FB; Olafsen T; Witte ON; Wu AM
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1108-13. PubMed ID: 24390540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel multifunctional
    Kwon YD; Lee JY; La MT; Lee SJ; Lee SH; Park JH; Kim HK
    Eur J Med Chem; 2020 Mar; 189():112099. PubMed ID: 32014792
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monitoring the Response of PD-L1 Expression to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Nonsmall-Cell Lung Cancer Xenografts by Immuno-PET Imaging.
    Li D; Zou S; Cheng S; Song S; Wang P; Zhu X
    Mol Pharm; 2019 Aug; 16(8):3469-3476. PubMed ID: 31283253
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM.
    Deng Z; Wu Y; Ma W; Zhang S; Zhang YQ
    BMC Immunol; 2015 Jan; 16(1):1. PubMed ID: 25636521
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo.
    Lanitis E; Poussin M; Klattenhoff AW; Song D; Sandaltzopoulos R; June CH; Powell DJ
    Cancer Immunol Res; 2013 Jul; 1(1):43-53. PubMed ID: 24409448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer
    Stutvoet TS; van der Veen EL; Kol A; Antunes IF; de Vries EFJ; Hospers GAP; de Vries EGE; de Jong S; Lub-de Hooge MN
    J Nucl Med; 2020 Dec; 61(12):1839-1844. PubMed ID: 32358092
    [No Abstract]   [Full Text] [Related]  

  • 78. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.
    Cheal SM; Punzalan B; Doran MG; Evans MJ; Osborne JR; Lewis JS; Zanzonico P; Larson SM
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):985-94. PubMed ID: 24604591
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.
    Zhao Y; Moon E; Carpenito C; Paulos CM; Liu X; Brennan AL; Chew A; Carroll RG; Scholler J; Levine BL; Albelda SM; June CH
    Cancer Res; 2010 Nov; 70(22):9053-61. PubMed ID: 20926399
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.
    Chin FT; Namavari M; Levi J; Subbarayan M; Ray P; Chen X; Gambhir SS
    Mol Imaging Biol; 2008; 10(2):82-91. PubMed ID: 18157580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.